Beaton; Graham

Patent Applications and Registrations

Patent applications and USPTO patent grants for Beaton; Graham.The latest application filed is for "inhibition of olig2 activity".

Company Profile

10.19.25

Beaton; Graham - San Diego CA
BEATON; Graham - Poway CA
Beaton; Graham - Boulder CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic compounds useful in the treatment of disease Grant 11,427,552 - Beaton , et al. August 30, 2	2022-08-30
Inhibition of OLIG2 activity Grant 11,242,323 - Beaton , et al. February 8, 2	2022-02-08
Inhibition Of Olig2 Activity App 20210347739 - BEATON; Graham ; et al.	2021-11-11
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20210284653 - BEATON; Graham ; et al.	2021-09-16
Inhibition Of Olig2 Activity App 20210253535 - BEATON; Graham ; et al.	2021-08-19
Chemoembolization Agents App 20210169801 - NA; James ; et al.	2021-06-10
Inhibition Of Olig2 Activity App 20210114991 - BEATON; Graham ; et al.	2021-04-22
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 10,941,159 - Beaton , et al. March 9, 2	2021-03-09
Inhibition Of Olig2 Activity App 20200407329 - BEATON; Graham ; et al.	2020-12-31
Heterocyclic Compounds Useful In The Treatment Of Disease App 20200181099 - BEATON; Graham ; et al.	2020-06-11
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20200095259 - BEATON; Graham ; et al.	2020-03-26
Heterocyclic compounds useful in the treatment of disease Grant 10,570,103 - Beaton , et al. Feb	2020-02-25
Heterocyclic compounds useful in the treatment of disease Grant 10,526,298 - Beaton , et al. J	2020-01-07
Inhibition Of Olig2 Activity App 20190389812 - BEATON; Graham ; et al.	2019-12-26
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 10,336,769 - Beaton , et al.	2019-07-02
Heterocyclic Compounds Useful In The Treatment Of Disease App 20190135767 - BEATON; Graham ; et al.	2019-05-09
Inhibition of OLIG2 activity Grant 10,227,333 - Beaton , et al.	2019-03-12
Heterocyclic Compounds Useful In The Treatment of Disease App 20180297962 - Beaton; Graham ; et al.	2018-10-18
Inhibition Of Olig2 Activity App 20180244631 - BEATON; Graham ; et al.	2018-08-30
Heterocyclic compounds useful in the treatment of disease Grant 10,000,459 - Beaton , et al. June 19, 2	2018-06-19
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20170320888 - Beaton; Graham ; et al.	2017-11-09
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 9,422,310 - Beaton , et al. August 23, 2	2016-08-23
Inhibition Of Olig2 Activity App 20160237069 - BEATON; Graham ; et al.	2016-08-18
Heterocyclic Compounds Useful In The Treatment Of Disease App 20160024031 - BEATON; Graham ; et al.	2016-01-28
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20150183800 - Beaton; Graham ; et al.	2015-07-02
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,952,161 - Beaton , et al. February 10, 2	2015-02-10
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20140024665 - Beaton; Graham ; et al.	2014-01-23
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,507,536 - Beaton , et al. August 13, 2	2013-08-13
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,481,738 - Beaton , et al. July 9, 2	2013-07-09
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20130040975 - Beaton; Graham ; et al.	2013-02-14
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,263,588 - Beaton , et al. September 11, 2	2012-09-11
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20120122891 - Beaton; Graham ; et al.	2012-05-17
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,084,614 - Beaton , et al. December 27, 2	2011-12-27
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20100184741 - Ashweek; Neil ; et al.	2010-07-22
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20100152207 - Beaton; Graham ; et al.	2010-06-17
Sleep inducing compounds and methods relating thereto Grant 7,393,865 - Beaton , et al. July 1, 2	2008-07-01
Sleep inducing compounds and methods relating thereto App 20060014797 - Beaton; Graham ; et al.	2006-01-19
Sleep inducing compounds and methods relating thereto App 20050277645 - Moree, Wilna (Willy) J. ; et al.	2005-12-15
PARP inhibitors Grant 6,924,284 - Beaton , et al. August 2, 2	2005-08-02
Parp inhibitors App 20040087588 - Beaton, Graham ; et al.	2004-05-06
Modified oligonucleotides and intermediates useful in nucleic acid therapeutics Grant 5,625,050 - Beaton , et al. April 29, 1	1997-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.